These inhibitors prevent the ADP-ribosylation of Axin, thereby stabilizing the protein and offering a potential therapeutic approach for cancer.410,411 Axin condensates promote phosphorylation by enriching the presence of CK1α over PP1 (Protein Phosphatase 1), thereby facilitating a higher rate of phosphorylation within the condensates. The gene discussed is AXIN1; the disease is cancer.